المؤلفون: Michel Soulié, Igor Latorzeff, Pierre Richaud, Stéphane Supiot, Olivier Gilliot, A. Benyoucef, David Azria, Marlon Silva, Sylvie Chabaud, Philippe Bergerot, David Pasquier, Pierre Graff-Cailleaud, Nicolas Magné, Menouar Samir Abdiche, Pierre Baumann, Meryem Brihoum, Yazid Belkacemi, Paul Sargos

المساهمون: CCSD, Accord Elsevier, Institut Bergonié [Bordeaux], UNICANCER, Centre Léon Bérard [Lyon], Clinique Pasteur, Clinique Pasteur [Toulouse], Institut de Cancérologie de la Loire Lucien Neuwirth, Centre Hospitalier Universitaire de Saint-Etienne (CHU de Saint-Etienne), Centre de Lutte Contre le Cancer Henri Becquerel Normandie Rouen (CLCC Henri Becquerel), Institut de Cancérologie de l'Ouest [Angers/Nantes] (UNICANCER/ICO), Centre Régional de Lutte contre le Cancer Oscar Lambret [Lille] (UNICANCER/Lille), Université de Lille-UNICANCER, Centre Hospitalier Robert Boulin, Partenaires INRAE, Clinique Marzet [Pau], Institut Claudius Regaud, Centre Régional de Lutte contre le Cancer François Baclesse [Caen] (UNICANCER/CRLC), Normandie Université (NU)-UNICANCER-Tumorothèque de Caen Basse-Normandie (TCBN), Clinique Mutualiste de l'Estuaire Cité Sanitaire [Saint Nazaire], Centre d'Oncologie de Gentilly, Hôpital Henri Mondor, Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12), Institut du Cancer de Montpellier (ICM), Centre Hospitalier Universitaire de Toulouse (CHU Toulouse), Université Lille Nord de France (COMUE)-UNICANCER, UNICANCER-Tumorothèque de Caen Basse-Normandie (TCBN)-Normandie Université (NU), Institut Mondor de Recherche Biomédicale (IMRB), Institut National de la Santé et de la Recherche Médicale (INSERM)-IFR10-Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12), CHU Toulouse [Toulouse], Centre Hospitalier Universitaire de Saint-Etienne [CHU Saint-Etienne] (CHU ST-E)

المصدر: Lancet Oncology
Lancet Oncology, 2020, 21, pp.1341-1352. ⟨10.1016/S1470-2045(20)30454-X⟩
Lancet Oncology, Elsevier, 2020, 21, pp.1341-1352. ⟨10.1016/S1470-2045(20)30454-X⟩

مصطلحات موضوعية: medicine.medical_specialty, medicine.medical_treatment, [SDV]Life Sciences [q-bio], Population, 030232 urology & nephrology, Androgen deprivation therapy, 03 medical and health sciences, Prostate cancer, 0302 clinical medicine, medicine, Clinical endpoint, 10. No inequality, Adverse effect, education, education.field_of_study, Prostatectomy, business.industry, medicine.disease, 3. Good health, Surgery, Radiation therapy, [SDV] Life Sciences [q-bio], Oncology, 030220 oncology & carcinogenesis, Hormonal therapy, business

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0764d48b07aa3c1f83d12a7e9fb86930
https://hal.science/hal-03491498/document

المؤلفون: Benoist Chibaudel, Frédéric Di Fiore, Gérard Lledo, Astrid Pozet, Pascal Artru, Nicolas Jovenin, Olivier Dupuis, Valérie Blondin, Mohamed Attia, Laurent Mineur, Aimery de Gramont, Laetitia Dahan, Menouar Samir Abdiche, Franck Bonnetain, Florence Huguet, Marie-Pierre Galais

المصدر: European Journal of Cancer. 56:115-121

مصطلحات موضوعية: 0301 basic medicine, Oncology, Cancer Research, medicine.medical_specialty, Time Factors, Esophageal Neoplasms, Organoplatinum Compounds, Leucovorin, Cetuximab, Phases of clinical research, Kaplan-Meier Estimate, Disease-Free Survival, 03 medical and health sciences, Folinic acid, 0302 clinical medicine, FOLFOX, Chemoimmunotherapy, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Prospective Studies, Neoplasm Staging, Proportional Hazards Models, business.industry, Radiotherapy Dosage, Chemoradiotherapy, digestive system diseases, Oxaliplatin, Regimen, Treatment Outcome, 030104 developmental biology, 030220 oncology & carcinogenesis, Esophagogastric Junction, Fluorouracil, France, business, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2254bd092d5e6aeee5a101aba2aec2d4
https://doi.org/10.1016/j.ejca.2015.12.020